What's breaking now, across thousands of outlets.
(MedPage Today) -- The FDA expanded its approval of mavacamten (Camzyos) to include children with symptomatic obstructive hypertrophic cardiomyopathy (HCM). Mavacamten thus becomes the first cardiac myosin inhibitor indicated for pediatric patients...
We haven't written up this one. MedPage Today has the full story — the link below goes straight to it.
New facility seeks to improve maternal and adolescent healthcare in Ga East Municipality.
A recent study using the end of post-war UK food rationing suggests that restricting sugar from conception to age two is linked to a significantly lower risk of developing anxiety and depression in…
[New Times] Africa's health-tech sector should produce its first billion-dollar company within the next five years, Jean-Philbert Nsengimana, Chairman of the Africa HealthTech Summit, has said.
The FCT Administration has approved the renovation and upgrading of 14 general hospitals and the resumption of work on the abandoned Utako General Hospital.
[Nile Post] As September comes to an end, we are reminded of an important issue affecting millions of people worldwide: suicide.
